Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06225362 · ClinicalTrials.gov registry record · NA

Quatera 700 vs. Centurion

A NA study of Cataract, sponsored by Carolina Eyecare Physicians.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06225362 is a NA study of Cataract that is active but no longer recruiting, run by Carolina Eyecare Physicians. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06225362, a NA study of Cataract, is active but no longer recruiting, sponsored by Carolina Eyecare Physicians.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Phacoemulsification is the most common treatment for cataract surgery in the developed countries and over the years it gained importance due to several factors: small incision, surgery performed under topical anesthesia - which reduce injection-related complications - short recovery time, low post operatory induced astigmatism, and low incidence of surgical complications, when compared to the conventional surgeries. The study evaluates 2 different phacoemulsification devices in patients undergoing routine cataract surgery in both eyes.

Conditions Studied

Interventions

  • DEVICE Quatera 700
  • DEVICE Centurion

Study Locations (1)

South Carolina

  • Carolina Eyecare Physicians, LLC - Mt. Pleasant

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-10
Est. Completion 2025-11-30
Phase NA

Sponsor

Carolina Eyecare Physicians

11 total trials

What the Registry Record Tells You About NCT06225362

The ClinicalTrials.gov registry entry for NCT06225362 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The listed sponsor is Carolina Eyecare Physicians, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Quatera 700 is the first listed.

NCT06225362 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06225362 about?

NCT06225362 is a clinical study titled "Quatera 700 vs. Centurion". Phacoemulsification is the most common treatment for cataract surgery in the developed countries and over the years it gained importance due to several factors: small incision, surgery performed under topical anesthesia - which reduce injection-related complications - short recovery time, low post o...

What is the current status of trial NCT06225362?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-01-10. Estimated completion is 2025-11-30.

What conditions does trial NCT06225362 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT06225362?

The interventions under investigation include: Quatera 700 (DEVICE), Centurion (DEVICE).

Who is sponsoring clinical trial NCT06225362?

This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06225362 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.